杂志简称：cancer nanotechnol
中文译名：《癌症纳米技术》
收录属性：scie（2024版）, 目次收录（维普）, 目次收录（知网）,英文期刊,
投稿方向：工程技术、nanoscience & nanotechnology纳米科技、oncology肿瘤学
SCI/E期刊基本信息
出版周期：年刊 地区：奥地利
中科院分区：3区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：OA期刊
国际标准刊号：ISSN 1868-6958；EISSN 1868-6966
杂志语言：英语
出版国家：奥地利
杂志官网 联系方式
出版地址：CAMPUS,4 CRINAN ST,LONDON,ENGLAND,N1 9XW
杂志邮箱：
投稿网址：https://submission.nature.com/new-submission/12645/3
杂志官方网址：https://cancer-nano.biomedcentral.com/
出版商网址：https://www.biomedcentral.com/
杂志投稿要求
投稿须知【杂志社官方网站信息】
Cancer Nanotechnology
Submission guidelines
Our 3-step submission process
Before you submit
Before you submit, we recommend familiarizing yourself with the following.
Make sure you are submitting to the most suitable journal – Aims and scope
Understand the costs and funding options – Fees and funding
Make sure your manuscript is accurate and readable – Language editing
Understand the copyright agreement – Copyright
Ready to submit
To give your manuscript the best chance of publication, follow these editorial policies and formatting guidelines.
Cancer Nanotechnology publishes the following article types:
Research
Case Report
Case Studies
Methodology
Review
Brief Report
Click the relevant link to find style and formatting information for the article you are going to submit.
General formatting rules for all article types – Prepare your manuscript
Make sure your submission is complete – Prepare supporting information
Copyright and license agreement – Agree to conditions
Read and agree to our Editorial Policies – Editorial Policies
Submit and promote
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond.
Who decides whether my work will be accepted? – Peer-review policy
Spreading the word – Promoting your publication
Submit manuscript
Aims and scope
Cancer is a group of diseases driven by inherently nanostructural problems (e.g. DNA issues). As such, there are obvious benefits to treatments employing nanoscale structures and processes. Additionally, as nanotechnologies are developing at a rapid rate, it is likely that many new themes will develop within the area in the next few years. With this in mind, Cancer Nanotechnology aims to provide a forum so that the most promising emerging themes should be pre-eminent in the minds of researchers working in one—or, indeed, both—of the disciplines of cancer research or nanotechnology.
Fees and funding
Article-processing charges
Open access publishing is not without costs. Cancer Nanotechnology therefore levies an article-processing charge of £1290.00/$1790.00/€1490.00 for each article accepted for publication, plus VAT or local taxes where applicable.
If the corresponding author's institution participates in our open access membership program, some or all of the publication cost may be covered (more details available on the membership page). We routinely waive charges for authors from low-income countries. For other countries, article-processing charge waivers or discounts are granted on a case-by-case basis to authors with insufficient funds. Authors can request a waiver or discount during the submission process. For further details, see our article-processing charge page.
Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.
Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.
For more information on APCs please see our Journal Pricing FAQs